H.C. Wainwright acted as sole placement agent in connection to the private placement of 71,428,572 shares in Relief Therapeutics Holding, a Swiss biopharmaceutical company listed at SIX Swiss Exchange, at a price of CHF 0.21 per share. The aggregate gross proceeds from the private placement are expected to be approximately CHF 15 million, before deducting the placement […]
Baker McKenzie has advised Société Générale and SG Issuer on the establishment of their first Swiss Structured Securities Issuance Program. The Program has been prepared in compliance with the new prospectus regime,
Homburger acted as legal counsel to UBS on its issuance of its inaugural green bonds, consisting of EUR 500 million, due June 2026. Along with CHF 250 million in aggregate principal amount of 0.150 per cent, due June 2028). senior
The partners and long-term employees of Schweizerische Treuhandgesellschaft in Basel have acquired the local entity from the current owners through a Management Buy-Out (Mbo). With the Mbo of the largest Stg-unit in Basel which occurred
Niederer Kraft Frey has advised Swiss global private banking group Julius Baer on the inaugural bond issuance by its wholly owned subsidiary and operating company, Bank Julius Baer & Co. EUR 500 million of the debut
Froriep acted as legal counsel to VanEck ETP and VanEck (Europe) in the launch of the VanEck Vectors Exchange Traded Notes Program at SIX. Froriep advised VanEck on the entire listing process for the multicurrency
Walder Wyss acted as legal counsel to Alentis Therapeutics on the USD 67 million series B financing round. Morningside Venture Investments led the financing, joined by Jeito Capital and Series A investors Biomed Partners, BB Pureos
Faveeo, a Swiss start-up operating an AI-driven trusted content platform, announced the successful closing of its Series B financing round. The investment was led by a private equity fund and various business angels. No financial
UBS Group completed its issuance of USD 750 m 3.875 per cent Tier 1 Capital Notes. The Notes are «high trigger» regulatory capital instruments that are eligible to fulfill UBS Group’s Swiss going concern requirements. The Notes
Froriep acted as legal counsel for Iconic Funds in the launch of its Iconic Funds Physical Bitcoin ETP at SIX, effective May 28, 2021. In particular, the law firm advised Iconic Funds on the entire listing process.
